Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 9, Issue 5, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-03-22
DOI
10.1093/ofid/ofac095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro Time Kill of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli using Cation Adjusted Muller Hinton Broth and ISO-Sensitest Broth
- (2022) Maxwell J. Lasko et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trimethoprim-Sulfamethoxazole Versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals
- (2022) Sadia H Sarzynski et al. Open Forum Infectious Diseases
- Effect of antimicrobials on Stenotrophomonas maltophilia biofilm
- (2021) Bárbara Ellen Santos Carvalhais et al. Future Microbiology
- Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan
- (2021) Rui-Xin Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- In Vitro Activity and In Vivo Efficacy of Cefiderocol Against Stenotrophomonas maltophilia
- (2021) Rio Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Performance of Manual Antimicrobial Susceptibility Testing Methods and Disk Breakpoints for Stenotrophomonas maltophilia
- (2021) Ayesha Khan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- StenoSCORE: Predicting Stenotrophomonas maltophilia Bloodstream Infections in the Hematologic Malignancy Population
- (2021) Sara M. Karaba et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advances in the Microbiology of Stenotrophomonas maltophilia
- (2021) Joanna S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy
- (2021) Shauna Jacobson Junco et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models
- (2021) Christian M Gill et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Stenotrophomonas maltophilia Susceptibility Testing Challenges and Strategies
- (2021) Daniel D. Rhoads JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia
- (2021) Ayesha Khan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study
- (2021) Lei Zha et al. Infectious Diseases and Therapy
- Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
- (2021) Pranita D Tamma et al. CLINICAL INFECTIOUS DISEASES
- Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update
- (2021) Emily N. Drwiega et al. CLINICAL PHARMACOKINETICS
- Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge
- (2020) Teresa Gil-Gil et al. Expert Review of Anti-Infective Therapy
- Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia
- (2020) Mercedes Delgado-Valverde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
- (2020) Matthias I. Gröschel et al. Nature Communications
- The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study
- (2020) Bin Cai et al. Open Forum Infectious Diseases
- Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy
- (2020) Samuel L Aitken et al. CLINICAL INFECTIOUS DISEASES
- Activity of aztreonam in combination with avibactam, clavulanate, relebactam, and vaborbactam against multidrug resistant Stenotrophomonas maltophilia
- (2020) M Biagi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
- (2020) Richard G Wunderink et al. LANCET INFECTIOUS DISEASES
- Optimization of Aztreonam in Combination with Ceftazidime/Avibactam in a Cystic Fibrosis Patient with Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring
- (2020) Mallory C. Cowart et al. THERAPEUTIC DRUG MONITORING
- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- Aztreonam plus clavulanate, tazobactam or avibactam for the treatment of metallo-β-lactamase-producing-Gram negative related infections
- (2019) Cécile Emeraud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of combination therapy versus monotherapy in the treatment of Stenotrophomonas maltophilia pneumonia
- (2019) Megan D Shah et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children
- (2019) Itay Tokatly Latzer et al. Pediatric Critical Care Medicine
- In vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models
- (2019) Rio Nakamura et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States
- (2019) Maria F. Mojica et al. mBio
- In Vitro Activity of Minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: Results from the SENTRY Antimicrobial Surveillance Program (2014-2018)
- (2019) Robert K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia infections
- (2019) Cara Nys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vivo Antibacterial Activity of Human-Simulated Exposures of Cefiderocol and Ceftazidime against Stenotrophomonas maltophilia in the Murine Thigh Model
- (2019) Iris H. Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of potential alternative treatment agents for Stenotrophomonas maltophilia non-susceptible to levofloxacin and/or trimethoprim/sulfamethoxazole
- (2019) M Biagi et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Implementation and optimization of molecular rapid diagnostic tests for bloodstream infections
- (2018) Eric Wenzler et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections
- (2018) Lucas Watson et al. Journal of Global Antimicrobial Resistance
- Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis
- (2018) J.-H. Ko et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series
- (2017) Hirotaka Ebara et al. INTERNAL MEDICINE
- Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia : in vitro effects and clinical efficacy in cancer patients
- (2017) Hideki Araoka et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Impacts of Penicillin Binding Protein 2 Inactivation on β-Lactamase Expression and Muropeptide Profile in Stenotrophomonas maltophilia
- (2017) Yi-Wei Huang et al. mSystems
- Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient
- (2016) Maria F. Mojica et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape
- (2016) R. M. Humphries et al. CLINICAL INFECTIOUS DISEASES
- Prevalence of Immunosuppression Among US Adults, 2013
- (2016) Rafael Harpaz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical outcomes using minocycline for Stenotrophomonas maltophilia infections
- (2016) Shauna Jacobson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment ofStenotrophomonas maltophiliainfections
- (2016) Elizabeth Hand et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints
- (2016) April M. Bobenchik et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Relationship of Sulfamethoxazole Therapeutic Drug Monitoring to Clinical Efficacy and Toxicity
- (2016) Lauren L. Ice et al. THERAPEUTIC DRUG MONITORING
- Tetracycline Antibiotics and Resistance
- (2016) Trudy H. Grossman Cold Spring Harbor Perspectives in Medicine
- Comparison of Monotherapy Versus Combination Therapy for Stenotrophomonas maltophilia Pneumonia Including Trimethoprim-Sulfamethoxazole-Containing and -Sparing Regimens
- (2016) Patrick Lake et al. Open Forum Infectious Diseases
- Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments
- (2016) Chuanqi Wei et al. PLoS One
- Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies
- (2016) Antoine Grillon et al. PLoS One
- The Efflux Pump SmeDEF Contributes to Trimethoprim-Sulfamethoxazole Resistance in Stenotrophomonas maltophilia
- (2015) María Blanca Sánchez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations
- (2015) Sung-Yeon Cho et al. BMC INFECTIOUS DISEASES
- Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience
- (2015) James A. McKinnell et al. CLINICAL INFECTIOUS DISEASES
- Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients
- (2015) Nicholas S. Britt et al. CLINICAL INFECTIOUS DISEASES
- Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
- (2015) Ya-Ting Chang et al. Frontiers in Microbiology
- A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused byStenotrophomonas maltophilia
- (2015) Chuanqi Wei et al. Infectious Diseases
- Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
- (2014) Yu-Chung Chuang et al. BMC INFECTIOUS DISEASES
- Interplay between intrinsic and acquired resistance to quinolones inStenotrophomonas maltophilia
- (2014) Guillermo García-León et al. ENVIRONMENTAL MICROBIOLOGY
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cotrimoxazole - optimal dosing in the critically ill
- (2014) Glen R Brown Annals of Intensive Care
- Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia
- (2013) Eleni P. Balli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream Infections
- (2013) Donald W. Whang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
- (2013) Yu Lin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia
- (2013) Julio Ramirez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
- (2012) P. D. Tamma et al. CLINICAL MICROBIOLOGY REVIEWS
- Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
- (2012) J. S. Brooke CLINICAL MICROBIOLOGY REVIEWS
- Tigecycline as a therapeutic option inStenotrophomonas maltophiliainfections
- (2012) Yasemin Tezer Tekçe et al. JOURNAL OF CHEMOTHERAPY
- Stenotrophomonas maltophilia Infections in a General Hospital: Patient Characteristics, Antimicrobial Susceptibility, and Treatment Outcome
- (2012) George Samonis et al. PLoS One
- Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron
- (2011) Li-Fen Hu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical and Microbiologic Outcomes in Trauma Patients Treated forStenotrophomonas maltophiliaVentilator-Associated Pneumonia
- (2011) Quinn A Czosnowski et al. PHARMACOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
- (2010) Ronald N. Jones CLINICAL INFECTIOUS DISEASES
- Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature
- (2009) Matthew E Falagas et al. Future Microbiology
- The versatility and adaptation of bacteria from the genus Stenotrophomonas
- (2009) Robert P. Ryan et al. NATURE REVIEWS MICROBIOLOGY
- Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants
- (2008) María B Sánchez et al. BMC MICROBIOLOGY
- Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review
- (2008) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants
- (2008) Lisa C Crossman et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More